🟢 Pharming Group is trading 7.27% up today after preliminary Q3 revenue topped expectations

Pharming Group is trading at €1.01, up 7.27%, after preliminary Q3 revenue exceeded market expectations.

• The October 23 gain followed its October 22 preliminary announcement: revenue was approximately US$117.6 million, up 21% year over year.
• RUCONEST and Joenja both contributed to growth; operating expenses were expected to be approximately US$74.6 million.
• The company tightened 2026 revenue guidance and lowered operating-expense guidance; full Q3 results are scheduled for October 27.